Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LEXX | AZN | AMGN | GILD | BMY |
| Company | Lexaria Bioscience Corp | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.7536 | 193.83 | 351.83 | 134.57 | 59.65 |
| High | 0.8000 | 194.64 | 351.83 | 136.63 | 60.06 |
| Low | 0.7440 | 192.61 | 348.13 | 133.89 | 59.08 |
| Latest | 0.7800 | 193.88 | 349.00 | 136.34 | 59.73 |
| Change | +0.0377 | +5.46 | +0.23 | +2.09 | +1.19 |
| % Change | +5.08% | +2.90% | +0.07% | +1.56% | +2.03% |
| Volume | 124,400 | 2,114,200 | 2,590,300 | 6,148,300 | 17,705,200 |
| 20-Day Average Volume | 141,065 | 1,905,680 | 2,648,090 | 6,274,840 | 13,873,186 |
| Previous Close | 0.7423 | 188.42 | 348.77 | 134.25 | 58.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7358 | 191.38 | 361.85 | 142.35 | 59.44 |
| 20-Day Raw Stochastic | 59.20% | 54.98% | 11.01% | 15.82% | 53.46% |
| 20-Day Relative Strength | 54.40 | 51.79 | 43.31 | 42.59 | 53.54 |
| Weighted Alpha | +8.54 | +40.42 | +20.30 | +27.14 | +18.01 |
| Today's Opinion | 40% Sell | 72% Buy | 40% Buy | 40% Buy | 88% Buy |
| Previous Opinion | 40% Sell | 40% Buy | 56% Buy | 40% Buy | 56% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.85% since 03/23/26 | +5.33% since 03/23/26 | -0.22% since 03/23/26 | -0.73% since 03/23/26 | +4.79% since 03/23/26 |
| Low | 0.7000 on 03/27/26 | 182.39 on 03/24/26 | 345.80 on 03/24/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 0.8400 on 03/26/26 | 194.64 on 03/30/26 | 358.00 on 03/25/26 | 140.41 on 03/25/26 | 60.06 on 03/30/26 |
| 1-Month | |||||
| %Chg | +11.59% since 02/27/26 | -6.99% since 02/27/26 | -10.09% since 02/27/26 | -8.47% since 02/27/26 | -4.23% since 02/27/26 |
| Low | 0.6349 on 03/03/26 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 0.8800 on 03/06/26 | 206.30 on 03/02/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +46.92% since 12/26/25 | +4.35% since 12/26/25 | +4.83% since 12/26/25 | +9.33% since 12/26/25 | +9.32% since 12/26/25 |
| Low | 0.4800 on 12/29/25 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 0.8800 on 03/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -25.71% since 09/26/25 | +31.43% since 09/26/25 | +27.85% since 09/26/25 | +21.62% since 09/26/25 | +35.38% since 09/26/25 |
| Low | 0.4600 on 12/26/25 | 147.37 on 09/29/25 | 270.67 on 09/29/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 1.4400 on 12/12/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,474 | 292,222,080 | 188,010,736 | 166,634,064 | 119,523,168 |
| Shares Outstanding, K | 24,887 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 710,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -11,900,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 170,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -2,700,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.54 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 01/13/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 04/13/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.02 | 16.16 | 16.80 | 9.66 |